Howard Group has confirmed the letting of Suite 4 in The Works, Unity Campus, to biotechnology company Maxion Therapeutics.

The 7,644 sq ft suite is fully fitted to CL2 laboratory standards and consists of two cell culture labs, an equipment room and two general-purpose labs, as well as a wash-up and store area.

Office and write-up space, plus ancillary meeting rooms and a kitchenette complete the suite.

Maxion is developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases.

The company is relocating from the Babraham Research Campus to facilitate further growth.

Unity Campus is well known to Maxion’s senior team. Prior to founding Maxion, chief executive officer John McCafferty and chief strategy officer Aneesh Karatt Vellatt co-founded antibody discovery company IONTAS, which moved to The Works in 2021 to facilitate a major expansion drive.

John McCafferty, chief executive officer of Maxion Therapeutics said: “Following our successful Series A fundraise earlier this year our team has rapidly grown, with the corresponding need for expanded facilities in the Cambridge area.

“We are excited to move to Unity Campus as we accelerate the development of our innovative pipeline of candidate therapeutics – with the ultimate goal of improving the quality of life of patients with debilitating disease conditions.”

Katherine Friend, director of investment and asset management at Howard Group said: “We are thrilled that Maxion Therapeutics has joined the Unity Campus community, and particularly pleased to welcome John McCafferty and Aneesh Karatt Vellatt back with their latest venture.

“Maxion joins an exciting and innovative Campus community which, in addition to undertaking ground-breaking research, also values the opportunity to interact and collaborate with each other outside the lab within the Campus ecosystem.

“The campus team provides a regular series of networking, professional development and social events to facilitate these interactions and we look forward to getting to know the Maxion Therapeutics team as they settle in over the next few weeks.”

© Eastern Echo (powered by

Sign up to receive our weekly free journal, The Forum here.